Colorado Central Cancer Registry
Provides complete statewide data on cancer
Cancer data and statistics
- Incidence rates.
A cancer incidence rate is the number of new cancers of a specific site/type occurring in a specified population during a year, usually expressed as the number of cancers per 100,000 people.
- Mortality rates.
A cancer mortality rate is the number of new deaths, with cancer as the underlying cause of death, occurring in a specified population during a year, usually expressed as the number of deaths due to cancer per 100,000 people.
- Stage of disease and early detection.
Stage of disease at the time of cancer diagnosis is typically defined by tumor size and how far the tumor has spread throughout the body. For cancer sites that have measurable survival benefits when found in the earliest stages, early detection is the percentage of staged cases that are diagnosed in the in situ or localized stages.
- Survival rates.
Survival rates are the proportion of patients alive at some point subsequent to the diagnosis of their cancer. This considers deaths from all causes, cancer or otherwise.
- Special reports.
More data and statistics on cancer
- North American Association of Central Cancer Registries: Cancer incidence statistics for about 35 states and all Canadian provinces, and cancer mortality for all 50 states and all Canadian provinces.
- Surveillance, Epidemiology and End Results (SEER program at National Cancer Institute): Cancer incidence and survival statistics for the SEER area, which covers about 14 percent of the U.S., and mortality rates for all 50 states.
- American Cancer Society: Statistics regarding cancer mortality over time, expected cancers by state and cancer risk factors.
- American College of Surgeons and National Cancer Database: Data management system for hospitals and programs approved by the Commission on Cancer. It's co-sponsored by the American College of Surgeons and the American Cancer Society. The database helps physicians, cancer registrars and hospital administrators improve the management of care for cancer patients, and comparative studies produced from the data serve as both a quality assessment tool and an agent for quality improvement in oncology care.